ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Here's why HDFC Securities recommends buying VRL Logistics, Natco Pharma
Logistics stocks have been showing strength on the medium term charts, according to Vinay Rajani of HDFC Securities.
Announcement as on 12 January 2022

Natco Pharma plans to launch Molnupiravir capsules this week for treatment of COVID-19
Molnupiravir is the first COVID-19 drug authorised by the Drugs Controller General of India (DCGI) for the treatment of COVID-19 infection in adults who have high risk of progression of the disease including hospitalisation or death.
Announcement as on 28 December 2021

Natco Pharma proposes to acquire Dash Pharmaceuticals
According to a press release issued by the Hyderabad-based drug maker, Dash is a front-end pharmaceutical sales, marketing and distribution entity based in New Jersey, USA which is expected to have approximate net sales of USD 15 million for the year endin
Announcement as on 14 December 2021

Natco Pharma launches novel fixed-dose combination drug for colorectal, gastric cancer
Natco Pharma has launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cancer, in the country. The company has launched the product under the brand name Tipanat in a pack of 20 tablets in a bot
Announcement as on 18 November 2021

Natco Pharma launches novel drug for colorectal, gastric cancer
Natco Pharma on Thursday said it has launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cancer, in the country. The company has launched the product under the brand name Tipanat in a pack of
Announcement as on 18 November 2021

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 789.55
  • 12Day Average: 788.68
  • 20Day Average: 801.68
  • 50Day Average: 831.01
  • 100Day Average: 874.7
  • 150Day Average: 943.99
  • 200Day Average: 931.32

524816 Indicators & signals

Indicator MACD (12,26,9)

792.78, 806.12, -14.51
Indicator MACD is in negative zone

Indicator ADX (14)

20.75, 11.83, 18.02
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 782.50 780.00 to 801.15 -0.67% 0.73 times
29 Thu Oct 2026 787.75 786.00 to 799.15 -0.71% 0.66 times
28 Wed Oct 2026 793.35 779.95 to 801.85 -0.09% 2.83 times
27 Tue Oct 2026 794.05 784.65 to 798.00 0.5% 0.45 times
26 Mon Oct 2026 790.10 782.85 to 796.15 -0.27% 0.63 times
23 Fri Oct 2026 792.20 778.00 to 796.70 0.85% 1.25 times
22 Thu Oct 2026 785.50 774.00 to 789.00 0.08% 0.99 times
21 Wed Oct 2026 784.90 779.45 to 808.95 -1.98% 0.55 times
19 Mon Oct 2026 800.75 778.75 to 809.75 1.97% 1.78 times
16 Fri Oct 2026 785.25 781.00 to 788.50 0.06% 0.25 times
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.61 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 0.88 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top